Stockscreener 앱 받기
15.55
0.78%
0.12
전일 마감가:
$15.43
열려 있는:
$15.42
하루 거래량:
509.41K
Relative Volume:
2.14
시가총액:
$1.47B
수익:
-
순이익/손실:
-
주가수익비율:
-
EPS:
-
순현금흐름:
-
1주 성능:
-6.77%
1개월 성능:
-13.13%
6개월 성능:
+0.00%
1년 성능:
+0.00%
1일 변동 폭
$15.02
$16.02
1주일 범위
$14.00
$17.23
52주 변동 폭
$14.00
$19.45
Lumexa Imaging Holdings Inc Stock (LMRI) Company Profile
LMRI을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
LMRI
Lumexa Imaging Holdings Inc
|
15.55 | 1.46B | 0 | 0 | 0 | 0.00 |
|
ABT
Abbott Laboratories
|
121.76 | 214.80B | 43.84B | 13.90B | 6.92B | 7.9725 |
|
SYK
Stryker Corp
|
363.78 | 138.62B | 24.38B | 2.94B | 4.07B | 7.6159 |
|
BSX
Boston Scientific Corp
|
88.07 | 133.46B | 19.35B | 2.78B | 3.82B | 1.8696 |
|
MDT
Medtronic Plc
|
96.76 | 126.92B | 34.76B | 4.79B | 5.21B | 3.7017 |
|
EW
Edwards Lifesciences Corp
|
84.35 | 49.03B | 5.88B | 1.34B | 799.60M | 2.3489 |
Lumexa Imaging Holdings Inc Stock (LMRI) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2026-01-05 | 개시 | Barclays | Overweight |
| 2026-01-05 | 개시 | Deutsche Bank | Buy |
| 2026-01-05 | 개시 | JP Morgan | Overweight |
| 2026-01-05 | 개시 | Jefferies | Buy |
| 2026-01-05 | 개시 | Leerink Partners | Outperform |
| 2026-01-05 | 개시 | Raymond James | Outperform |
| 2026-01-05 | 개시 | Wells Fargo | Overweight |
| 2026-01-05 | 개시 | William Blair | Outperform |
모두보기
Lumexa Imaging Holdings Inc 주식(LMRI)의 최신 뉴스
Lumexa Imaging Holdings, Inc.’s Quiet Period Set To End on January 20th (NASDAQ:LMRI) - Defense World
Lumexa Imaging Holdings chief legal officer Julie Szeker to resign in March - Investing.com Nigeria
Lumexa Imaging Holdings, Inc. Announces Resignation of Chief Legal Officer and Corporate Secretary Julie Szeker, Effective March 13, 2026 - marketscreener.com
Lumexa Imaging Holdings chief legal officer Julie Szeker to resign in March By Investing.com - Investing.com South Africa
Lumexa Imaging Announces Chief Legal Officer Resignation - TipRanks
Assessing Lumexa Imaging Holdings (LMRI) Valuation After Recent Share Price Pullback - Yahoo Finance
LMRI: Global radiopharma leader drives growth with late-stage oncology pipeline and strategic expansion - TradingView — Track All Markets
Lumexa Imaging: Resilient Demand With Compounding Scale Moat (NASDAQ:LMRI) - Seeking Alpha
Lumexa Imaging Holdings, Inc.Common Stock (NQ: LMRI - FinancialContent
Lumexa Imaging Achieves Record De Novo Expansion in 2025 - Sahm
Lumexa Imaging Holdings, Inc.: Revenue and Earnings Analysts Forecasts Revisions | LMRI | US5502491062 - MarketScreener
Lumexa Imaging Holdings, Inc.: Target Price Consensus and Analysts Recommendations | LMRI | US5502491062 - MarketScreener
Lumexa Imaging Holdings, Inc.: Dividend historical data and projections - MarketScreener
Analysts Offer Insights on Technology Companies: Advanced Micro Devices (AMD) and Lumexa Imaging Holdings, Inc. (LMRI) - The Globe and Mail
Analysts Offer Insights on Technology Companies: Broadcom (AVGO), Lumexa Imaging Holdings, Inc. (LMRI) and Apple (AAPL) - The Globe and Mail
Lumexa Imaging Holdings: Leveraging Outpatient Growth and JV Model to Drive Premium-Valued Expansion and Deleveraging Upside - TipRanks
Lumexa Imaging Announces Participation in Upcoming January 2026 Investor Conference - BioSpace
Lumexa Imaging Announces Participation in Upcoming Investor Conf - GuruFocus
Lumexa Imaging Announces Participation in Upcoming Investor Conference - Finviz
Lumexa Imaging Holdings: Secular Tailwinds, High-Return Expansion, and Joint-Venture Model Support Buy Rating - TipRanks
Lumexa Imaging Draws Bullish Analyst Calls On Heels Of IPO - One News Page
Deutsche Bank Initiates Lumexa Imaging at Buy With $22 Price Target - marketscreener.com
Deutsche Bank initiates coverage on Lumexa Imaging stock with Buy rating - Investing.com Canada
JPMorgan Initiates Lumexa Imaging at Overweight With $23 Price Target - marketscreener.com
Jefferies Initiates Lumexa Imaging at Buy With $23 Price Target - marketscreener.com
Barclays Initiates Lumexa Imaging at Overweight With $23 Price Target - marketscreener.com
Leerink Partners Initiates Lumexa Imaging at Outperform With $23 Price Target - marketscreener.com
This vTv Therapeutics Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday - Benzinga
LMRI Archives - 24/7 Wall St.
Wells Fargo initiates Lumexa Imaging stock with Overweight rating By Investing.com - Investing.com Canada
Lumexa Imaging stock initiated with Outperform rating by William Blair - Investing.com
Lumexa Imaging Holdings: Capitalizing on Outpatient Imaging Tailwinds with Sustainable Growth and Attractive Risk-Reward - TipRanks
Raymond James initiates Lumexa Imaging stock with Outperform rating By Investing.com - Investing.com Canada
Jefferies initiates coverage on Lumexa Imaging stock with Buy rating By Investing.com - Investing.com Nigeria
JPMorgan initiates Lumexa Imaging stock with Overweight rating, $23 target By Investing.com - Investing.com Canada
Jefferies initiates coverage on Lumexa Imaging stock with Buy rating - Investing.com
Lumexa Imaging Holdings, Inc. (LMRI) - Zacks Investment Research
Lumexa Imaging refinances debts, fills out board of directors - Radiology Business
Lumexa Imaging Secures New Long-Term Senior Credit Facilities - TipRanks
Lumexa Imaging Signs Amended Credit Agreement With Barclays Bank - TradingView — Track All Markets
LUMEXA IMAGING HOLDINGS INC (LMRI) Stock Technical Analysis - Chartmill
Lumexa Imaging (LMRI) awards 8,464 restricted stock units to CMO - Stock Titan
Lumexa Imaging no longer controlled by private equity following IPO - Radiology Business
Welsh Carson scores IPO exit as Lumexa Imaging raises $463m in US debut - Private Equity Insights
Lumexa Imaging Holdings Inc (LMRI) 재무 분석
Lumexa Imaging Holdings Inc (LMRI)에 대한 금융 데이터가 없습니다. 더 많은 정보를 위해 다른 주식을 확인해보세요.
매출
순이익
현금흐름
주당 순 이익
0.42%
1.96%
자본화:
|
볼륨(24시간):